de.mpg.escidoc.pubman.appbase.FacesBean
English
 
Help Guide Disclaimer Contact us Login
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

GABAA receptor-modulating neuroactive steroid composition in patients with panic disorder before and during paroxetine treatment

MPS-Authors

Ströhle,  A
Max Planck Institute of Psychiatry, Max Planck Society;

Romeo,  E
Max Planck Institute of Psychiatry, Max Planck Society;

di Michele,  F
Max Planck Institute of Psychiatry, Max Planck Society;

Pasini,  A
Max Planck Institute of Psychiatry, Max Planck Society;

Yassouridis,  A
Max Planck Institute of Psychiatry, Max Planck Society;

Holsboer,  F
Max Planck Institute of Psychiatry, Max Planck Society;

Rupprecht,  R
Max Planck Institute of Psychiatry, Max Planck Society;

Locator
There are no locators available
Fulltext (public)
There are no public fulltexts available
Supplementary Material (public)
There is no public supplementary material available
Citation

Ströhle, A., Romeo, E., di Michele, F., Pasini, A., Yassouridis, A., Holsboer, F., et al. (2002). GABAA receptor-modulating neuroactive steroid composition in patients with panic disorder before and during paroxetine treatment. American Journal of Psychiatry, 159(1), 145-147.


Cite as: http://hdl.handle.net/11858/00-001M-0000-000E-A263-7
Abstract
Objective: Previous studies have shown that neuroactive steroids modulate anxiety and stress reactivity. However, no data on the possible role of these gamma-aminobutyric acid(A) (GABA(A)) receptor-modulating neuroactive steroids in patients with anxiety disorders are available. Method: The concentrations of 3alpha,5alpha-tetrahydroprogesterone (3alpha,5alpha-THP), 3alpha,5beta-THP, 3beta,5alpha-THP, and their precursors were studied in the plasma of 10 patients with panic disorder and 10 matched healthy comparison subjects. In addition, the effects of paroxetine treatment on neuroactive Steroid concentrations were studied in the panic disorder patients over a 24-week period. Results: Unexpectedly, patients with panic disorder had significantly greater concentrations of the positive allosteric modulators 3alpha,5alpha-THP and 3alpha,5beta-THP and significantly lower concentrations of 3beta,5alpha-THP (a functional antagonist for GABAA agonistic steroids), which might result in greater GABA(A) receptor- mediated neuronal activity. Paroxetine treatment did not affect neuroactive steroid concentrations, which were highly stable over 24 weeks. Conclusions. Differences in neuroactive steroid composition in patients with panic disorder were the opposite of those seen in patients with major depression and may reflect counter-regulative mechanisms against the occurrence of spontaneous panic attack